MAPT and Parkinson disease: Low O‐GlcNAcylation can cause abnormal Tau aggregation in AD, α‐synuclein accumulation and dopamine neuron loss in PD, dysfunction of NPCs in HD, and impaired functions of NF, TDP‐43, and NPGPx in ALS.